Patents by Inventor Lunyin Yu

Lunyin Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT AND PREVENTION OF ABNORMAL CELLULAR PROLIFERATION
    Publication number: 20090220606
    Abstract: This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative. Abnormal growth of cells refers to cell growth independent of normal regulatory mechanism (e.g. loss of contact inhibition). This includes the abnormal growth of: (1) tumor cells (tumors); (2) benign and malignant cells of other proliferative disease in which aberrant cellular proliferation occurs; (3) aberrant smooth muscle cell proliferation, such as might occur following treatment for coronary atherosclerosis such as angioplasty or the insertion of a stent into an occluded vessel.
    Type: Application
    Filed: April 20, 2009
    Publication date: September 3, 2009
    Inventors: Charles A. Hales, Hari G. Garg, Lunyin Yu, Robert J. Linhardt
  • Treatment and prevention of abnormal cellular proliferation
    Patent number: 7538096
    Abstract: This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative. Abnormal growth of cells refers to cell growth independent of normal regulatory mechanism (e.g. loss of contact inhibition). This includes the abnormal growth of: (1) tumor cells (tumors); (2) benign and malignant cells of other proliferative disease in which aberrant cellular proliferation occurs; (3) aberrant smooth muscle cell proliferation, such as might occur following treatment for coronary atherosclerosis such as angioplasty or the insertion of a stent into an occluded vessel.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: May 26, 2009
    Assignees: The General Hospital Corporation, The University of Iowa Research Foundation
    Inventors: Charles A. Hales, Hari G. Garg, Lunyin Yu, Robert J Linhardt
  • Treatment and prevention of abnormal cellular proliferation
    Publication number: 20050288251
    Abstract: This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative. Abnormal growth of cells refers to cell growth independent of normal regulatory mechanism (e.g. loss of contact inhibition). This includes the abnormal growth of: (1) tumor cells (tumors); (2) benign and malignant cells of other proliferative disease in which aberrant cellular proliferation occurs; (3) aberrant smooth muscle cell proliferation, such as might occur following treatment for coronary atherosclerosis such as angioplasty or the insertion of a stent into an occluded vessel.
    Type: Application
    Filed: March 16, 2005
    Publication date: December 29, 2005
    Applicants: The General Hospital Corporation, The University of Iowa Research Foundation
    Inventors: Charles Hales, Hari Garg, Lunyin Yu, Robert Linhardt